SCHEMBL4367215

SCHEMBL4367215

NC(=S)Nc1cccc(-c2ccc(N3CCCCC3)c(F)c2)c1C(=O)c1cc2ccccc2o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.50
NPSR1 Q6W5P4 4/20 0.50
MAPT P10636 3/20 0.50
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
KDM4E B2RXH2 3/20 0.50
ATM Q13315 2/20 0.50
TP53 P04637 1/20 0.50
HTT P42858 1/20 0.50
LMNA P02545 2/20 0.45
RAB9A P51151 3/20 0.44
HPGD P15428 3/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
MEN1 O00255 1/20 0.40
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4367217 0.83 NPC1 (0.46) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4367212 0.82 MAPT (0.43) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4375271 0.81 FLT3 (0.52) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4374067 0.75 NPC1 (0.52) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL13956757 0.74 NPC1 (0.66) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL14096111 0.73 NPC1 (0.64) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4361783 0.70 KDM4E (0.42) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4357780 0.69 MAOB (0.52) NPC1NPSR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4361608 0.66 HDAC3 (0.45) NPC1MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL4361601 0.66 RAB9A (0.43) NPC1MAPTALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US claimed
EP-1562895-A1 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION Achillion Pharmaceuticals, Inc. (US) 2005-08-17 EP claimed
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2004-07-15 US claimed
WO-2004046095-A1 SUBSTITUTED ARYL THIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2004-06-03 WO claimed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, TPMT NPC1 107/4885NPSR1 3874/4885MAPT 3454/4885
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 NPC1 151/4885NPSR1 3386/4885MAPT 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.